ENAS 880...Imaging Drugs in the Brain | Fall 2014 | ||||||||||||||
Draft Syllabus | |||||||||||||||
DATE | room | Lect | TOPIC | ARTICLES | Supporting docs | INSTRUCTOR(s) | |||||||||
2-Sep | TAC N205 | 1 | introduction to PET and neuroreceptor imaging | Morris,Lucas,Cosgrove | Fowler 2007 | Morris | |||||||||
9-Sep | TAC N205 | 2 | imaging dopamine receptors, drugs | Wagner 1983 | Farde 1986 | Mintun 1984 | Morris | ||||||||
16-Sep | TAC N205 | 3 | imaging dopamine changes (displacement) | Logan 1991 | Morris 1995 | Koepp 1998 | Fisher 1995 | Morris | |||||||
23-Sep | TAC N205 | 4 | equilibrium vs bolus designs | Carson 2000 | Marenco 2004 | Watabe 2000 | Morris | ||||||||
30-Sep | TAC N205 | 5 | fMRI basics/comparison to PET | TBP | TBP | TBP | Hampson/Morris | ||||||||
7-Oct | TAC N205 | 6 | alcohol induced dopamine | Yoder 2009 | Urban 2010 | Boileau 2003 | Cosgrove/Morris | ||||||||
14-Oct | TAC N205 | 7 | smoking/imaging nicotinic receptors w SPECT | Cosgrove 2009 | Brody 2011 | Cosgrove | |||||||||
21-Oct | TAC N205 | smoking/dopamine study comparison | Brody 2004 | Barrett 2004 | Scott 2007 | Morris/Cosgrove | |||||||||
28-Oct | TAC N205 | 8 | animal models of drug use | Sandiego 2013 | Morgan 2002 | Lefoll 2009 | Cosgrove | ||||||||
4-Nov | TAC N205 | 9 | alccoholism/opioid receptors/NTX occupancy | Weerts 2008 | Krishnan-Sarin 2007 | Kim 2013 | Morris | ||||||||
11-Nov | TAC N205 | 10 | imaging brain inflammation - anti inflam drugs | TBP | TBP | TBP | Cosgrove/Morris | ||||||||
18-Nov | TAC N205 | 11 | Functional connectivity for study of drugs | TBP | TBP | TBP | Hampson | ||||||||
25-Nov | TAC N205 | 12 | BREAK | ||||||||||||
2-Dec | TAC N205 | 13 | PhMRI vs PET what do they measure? | TBP | TBP | TBP | Hampson/Morris/Cosgrove | ||||||||
16-Dec | TAC N205 | 14 | Final "Design-a-thon" | Guest judges | |||||||||||
KEY: | means "tentative" | ||||||||||||||
means: no synopsis required | |||||||||||||||
Removed Lectures | |||||||||||||||
short-lived dopamine release/smoking | 1. PAR-12-267 | Sullivan 2013 | Morris 2013 | ||||||||||||
2. FDA/CTP priorities | |||||||||||||||
obesity fMRI v PET | Wang 2000 | Stice, 2008 | Cosgrove ? | Wang,Volkow | |||||||||||
additional obesity paper | Eisenstein 2013 | ||||||||||||||
basics of fMRI | Clare 2009 | Poldrack 2009 | Buxton | ||||||||||||
supplementary material | Ernst 1999 |